Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Atrial Fibrillation | 232 | 2024 | 5209 | 14.070 |
Why?
|
Warfarin | 119 | 2024 | 1518 | 9.690 |
Why?
|
Anticoagulants | 171 | 2024 | 4897 | 9.080 |
Why?
|
Stroke | 151 | 2024 | 9962 | 6.730 |
Why?
|
Vitamin K | 33 | 2024 | 321 | 3.210 |
Why?
|
Hemorrhage | 63 | 2024 | 3600 | 2.800 |
Why?
|
Intracranial Hemorrhages | 16 | 2024 | 844 | 2.400 |
Why?
|
International Normalized Ratio | 24 | 2021 | 386 | 2.330 |
Why?
|
Brain Ischemia | 21 | 2019 | 3127 | 2.310 |
Why?
|
Embolism | 28 | 2024 | 408 | 2.260 |
Why?
|
Blood Coagulation | 16 | 2021 | 1157 | 2.260 |
Why?
|
Thromboembolism | 21 | 2018 | 1017 | 2.040 |
Why?
|
Morpholines | 27 | 2024 | 583 | 1.960 |
Why?
|
Smoking Cessation | 18 | 2023 | 2064 | 1.800 |
Why?
|
Thiophenes | 26 | 2024 | 587 | 1.770 |
Why?
|
Anti-Arrhythmia Agents | 16 | 2021 | 784 | 1.650 |
Why?
|
Administration, Oral | 55 | 2024 | 4035 | 1.460 |
Why?
|
Aged | 278 | 2024 | 169152 | 1.320 |
Why?
|
Fibrinolytic Agents | 18 | 2024 | 2167 | 1.300 |
Why?
|
Cerebrovascular Disorders | 22 | 2013 | 1501 | 1.270 |
Why?
|
Registries | 41 | 2023 | 8469 | 1.270 |
Why?
|
Risk Assessment | 50 | 2024 | 24123 | 1.180 |
Why?
|
Risk Factors | 153 | 2024 | 74359 | 1.100 |
Why?
|
Aged, 80 and over | 133 | 2024 | 58995 | 1.090 |
Why?
|
Electrocardiography | 16 | 2024 | 6414 | 1.080 |
Why?
|
Sciatica | 12 | 2006 | 97 | 1.070 |
Why?
|
Pneumonia | 31 | 2002 | 2131 | 1.000 |
Why?
|
Male | 320 | 2024 | 359744 | 1.000 |
Why?
|
Community-Acquired Infections | 27 | 2002 | 461 | 1.000 |
Why?
|
Female | 330 | 2024 | 391270 | 0.970 |
Why?
|
Drug Monitoring | 8 | 2019 | 965 | 0.910 |
Why?
|
Primary Health Care | 16 | 2024 | 4647 | 0.900 |
Why?
|
Humans | 436 | 2024 | 760621 | 0.900 |
Why?
|
Spinal Stenosis | 9 | 2005 | 262 | 0.780 |
Why?
|
Gastrointestinal Hemorrhage | 3 | 2019 | 1131 | 0.770 |
Why?
|
Patient Discharge | 17 | 2023 | 3476 | 0.750 |
Why?
|
Atrial Flutter | 5 | 2017 | 258 | 0.730 |
Why?
|
Aspirin | 25 | 2018 | 3364 | 0.720 |
Why?
|
Middle Aged | 216 | 2024 | 220352 | 0.720 |
Why?
|
Electric Countershock | 9 | 2020 | 537 | 0.710 |
Why?
|
Coagulants | 1 | 2020 | 46 | 0.700 |
Why?
|
Muscle Rigidity | 1 | 2019 | 40 | 0.680 |
Why?
|
Factor VIIa | 1 | 2020 | 103 | 0.670 |
Why?
|
Frail Elderly | 2 | 2024 | 752 | 0.660 |
Why?
|
Treatment Outcome | 101 | 2024 | 65017 | 0.660 |
Why?
|
Follow-Up Studies | 64 | 2024 | 39261 | 0.640 |
Why?
|
Defibrillators, Implantable | 7 | 2018 | 1499 | 0.630 |
Why?
|
Blood Coagulation Factors | 2 | 2020 | 365 | 0.630 |
Why?
|
Diabetes Mellitus | 15 | 2022 | 5889 | 0.630 |
Why?
|
Intestinal Obstruction | 1 | 2022 | 434 | 0.620 |
Why?
|
Lumbar Vertebrae | 11 | 2006 | 1868 | 0.620 |
Why?
|
Pyridones | 8 | 2024 | 792 | 0.610 |
Why?
|
Time Factors | 59 | 2024 | 40165 | 0.600 |
Why?
|
Incidence | 40 | 2024 | 21392 | 0.590 |
Why?
|
Thoracic Wall | 1 | 2019 | 199 | 0.590 |
Why?
|
California | 12 | 2019 | 1416 | 0.580 |
Why?
|
Plasma | 2 | 2020 | 584 | 0.580 |
Why?
|
Ambulatory Care | 13 | 2016 | 2781 | 0.560 |
Why?
|
Naloxone | 1 | 2019 | 369 | 0.560 |
Why?
|
Reminder Systems | 2 | 2017 | 387 | 0.560 |
Why?
|
Crotalid Venoms | 1 | 2016 | 29 | 0.550 |
Why?
|
Venous Thromboembolism | 8 | 2021 | 1864 | 0.540 |
Why?
|
Hospitalization | 32 | 2022 | 10790 | 0.540 |
Why?
|
Drug Dosage Calculations | 3 | 2018 | 118 | 0.540 |
Why?
|
Counseling | 8 | 2022 | 1548 | 0.530 |
Why?
|
Withholding Treatment | 4 | 2021 | 613 | 0.510 |
Why?
|
Cohort Studies | 57 | 2024 | 41335 | 0.510 |
Why?
|
Age Factors | 32 | 2021 | 18416 | 0.510 |
Why?
|
Prospective Studies | 87 | 2022 | 54303 | 0.510 |
Why?
|
Renal Insufficiency, Chronic | 8 | 2023 | 2290 | 0.510 |
Why?
|
Platelet Aggregation Inhibitors | 15 | 2020 | 3201 | 0.480 |
Why?
|
Diskectomy | 6 | 2005 | 209 | 0.480 |
Why?
|
Narcotic Antagonists | 1 | 2019 | 583 | 0.480 |
Why?
|
Randomized Controlled Trials as Topic | 25 | 2024 | 10344 | 0.470 |
Why?
|
Natural Language Processing | 2 | 2024 | 1135 | 0.470 |
Why?
|
United States | 70 | 2024 | 72461 | 0.470 |
Why?
|
Tobacco Use Disorder | 5 | 2018 | 700 | 0.470 |
Why?
|
Mass Screening | 12 | 2024 | 5423 | 0.460 |
Why?
|
Comorbidity | 29 | 2023 | 10551 | 0.460 |
Why?
|
Point-of-Care Systems | 2 | 2022 | 1204 | 0.460 |
Why?
|
Double-Blind Method | 33 | 2024 | 12427 | 0.440 |
Why?
|
Cerebral Hemorrhage | 8 | 2024 | 2660 | 0.440 |
Why?
|
Pyrazoles | 8 | 2024 | 1999 | 0.430 |
Why?
|
Blood Glucose | 14 | 2016 | 6381 | 0.430 |
Why?
|
Sweden | 3 | 2024 | 1381 | 0.420 |
Why?
|
Respiratory Tract Infections | 4 | 2003 | 1007 | 0.400 |
Why?
|
Electronic Health Records | 11 | 2024 | 4775 | 0.400 |
Why?
|
Research Design | 9 | 2021 | 6180 | 0.380 |
Why?
|
Proportional Hazards Models | 24 | 2024 | 12531 | 0.380 |
Why?
|
Adult | 117 | 2024 | 219994 | 0.370 |
Why?
|
Patient Satisfaction | 13 | 2019 | 3448 | 0.350 |
Why?
|
Guideline Adherence | 6 | 2019 | 2283 | 0.350 |
Why?
|
Drug Prescriptions | 5 | 2018 | 1673 | 0.350 |
Why?
|
Electrocardiography, Ambulatory | 5 | 2022 | 578 | 0.350 |
Why?
|
Health Knowledge, Attitudes, Practice | 7 | 2019 | 3986 | 0.340 |
Why?
|
Thrombolytic Therapy | 5 | 2018 | 2108 | 0.340 |
Why?
|
Pregnancy in Adolescence | 5 | 1998 | 162 | 0.340 |
Why?
|
Kidney Function Tests | 4 | 2021 | 681 | 0.340 |
Why?
|
Multivariate Analysis | 22 | 2021 | 12159 | 0.340 |
Why?
|
Predictive Value of Tests | 21 | 2024 | 15289 | 0.330 |
Why?
|
Drug Substitution | 4 | 2024 | 296 | 0.330 |
Why?
|
Drug Utilization | 6 | 2004 | 1195 | 0.330 |
Why?
|
Intracranial Embolism | 6 | 2019 | 192 | 0.320 |
Why?
|
Quality of Life | 24 | 2020 | 13308 | 0.320 |
Why?
|
Prevalence | 24 | 2023 | 15687 | 0.320 |
Why?
|
Logistic Models | 26 | 2019 | 13314 | 0.310 |
Why?
|
Kazakhstan | 3 | 2023 | 19 | 0.310 |
Why?
|
Medication Adherence | 4 | 2024 | 2165 | 0.310 |
Why?
|
Ischemic Attack, Transient | 8 | 2018 | 901 | 0.310 |
Why?
|
Prognosis | 24 | 2024 | 29658 | 0.300 |
Why?
|
Antithrombins | 4 | 2021 | 313 | 0.300 |
Why?
|
Smoking | 8 | 2017 | 9073 | 0.290 |
Why?
|
Case-Control Studies | 18 | 2024 | 22053 | 0.290 |
Why?
|
Telephone | 5 | 2021 | 624 | 0.290 |
Why?
|
Boston | 18 | 2020 | 9280 | 0.290 |
Why?
|
Severity of Illness Index | 27 | 2021 | 15840 | 0.290 |
Why?
|
Retrospective Studies | 48 | 2024 | 80372 | 0.290 |
Why?
|
Dose-Response Relationship, Drug | 17 | 2019 | 10827 | 0.290 |
Why?
|
Workers' Compensation | 4 | 2006 | 150 | 0.280 |
Why?
|
Comparative Effectiveness Research | 5 | 2023 | 718 | 0.280 |
Why?
|
Manipulation, Orthopedic | 2 | 1996 | 40 | 0.280 |
Why?
|
Aftercare | 4 | 2023 | 916 | 0.270 |
Why?
|
Quality-Adjusted Life Years | 6 | 2020 | 1724 | 0.270 |
Why?
|
Length of Stay | 16 | 2017 | 6479 | 0.270 |
Why?
|
Pulmonary Embolism | 4 | 2021 | 2543 | 0.270 |
Why?
|
Europe | 6 | 2020 | 3441 | 0.270 |
Why?
|
Heart Rate | 5 | 2023 | 4179 | 0.260 |
Why?
|
Digoxin | 3 | 2015 | 247 | 0.260 |
Why?
|
Venous Thrombosis | 3 | 2021 | 1299 | 0.260 |
Why?
|
Oligosaccharides | 1 | 2008 | 405 | 0.260 |
Why?
|
Catheter Ablation | 5 | 2020 | 2758 | 0.250 |
Why?
|
Survival Rate | 15 | 2021 | 12808 | 0.250 |
Why?
|
Factor Xa | 4 | 2015 | 168 | 0.250 |
Why?
|
Amiodarone | 2 | 2019 | 218 | 0.250 |
Why?
|
Polypharmacy | 5 | 2019 | 307 | 0.250 |
Why?
|
Cardiovascular Diseases | 14 | 2022 | 15757 | 0.250 |
Why?
|
Brain Damage, Chronic | 1 | 2006 | 267 | 0.250 |
Why?
|
Databases, Factual | 7 | 2021 | 8035 | 0.240 |
Why?
|
Asia | 3 | 2020 | 620 | 0.240 |
Why?
|
Abdominal Injuries | 2 | 2005 | 359 | 0.240 |
Why?
|
Bupropion | 1 | 2006 | 304 | 0.240 |
Why?
|
Decision Support Techniques | 7 | 2019 | 2001 | 0.240 |
Why?
|
Societies, Medical | 3 | 2013 | 3905 | 0.240 |
Why?
|
Diabetes Mellitus, Type 2 | 20 | 2004 | 12293 | 0.230 |
Why?
|
Wounds, Nonpenetrating | 3 | 2005 | 793 | 0.230 |
Why?
|
Evidence-Based Medicine | 5 | 2012 | 3696 | 0.230 |
Why?
|
Pennsylvania | 9 | 2020 | 615 | 0.230 |
Why?
|
Odds Ratio | 14 | 2017 | 9716 | 0.230 |
Why?
|
Cause of Death | 8 | 2019 | 3725 | 0.230 |
Why?
|
Hypertension | 15 | 2022 | 8594 | 0.220 |
Why?
|
Antidepressive Agents, Second-Generation | 1 | 2006 | 489 | 0.220 |
Why?
|
Office Visits | 5 | 2019 | 597 | 0.210 |
Why?
|
Residence Characteristics | 1 | 2013 | 2062 | 0.210 |
Why?
|
Myocardial Infarction | 12 | 2022 | 11891 | 0.210 |
Why?
|
Propensity Score | 6 | 2024 | 1928 | 0.210 |
Why?
|
Patient Admission | 4 | 2000 | 1386 | 0.210 |
Why?
|
Cross-Over Studies | 2 | 2021 | 2061 | 0.210 |
Why?
|
Disability Evaluation | 7 | 2017 | 1826 | 0.210 |
Why?
|
Hospitals, Teaching | 5 | 2012 | 1166 | 0.210 |
Why?
|
Dementia | 3 | 2023 | 2649 | 0.200 |
Why?
|
Outpatient Clinics, Hospital | 4 | 2013 | 389 | 0.200 |
Why?
|
Kidney | 4 | 2020 | 7064 | 0.200 |
Why?
|
Drug Therapy, Combination | 12 | 2019 | 6498 | 0.200 |
Why?
|
Factor V | 1 | 2003 | 168 | 0.200 |
Why?
|
Angina, Unstable | 1 | 2006 | 926 | 0.200 |
Why?
|
North America | 3 | 2015 | 1284 | 0.200 |
Why?
|
Drug Administration Schedule | 10 | 2020 | 4899 | 0.190 |
Why?
|
Latin America | 3 | 2021 | 404 | 0.190 |
Why?
|
Massachusetts | 15 | 2019 | 8803 | 0.190 |
Why?
|
Patient Compliance | 7 | 2014 | 2688 | 0.190 |
Why?
|
Biomedical Research | 3 | 2021 | 3426 | 0.190 |
Why?
|
Risk | 19 | 2016 | 9631 | 0.190 |
Why?
|
Glucose Tolerance Test | 3 | 2002 | 1175 | 0.190 |
Why?
|
Data Collection | 5 | 2014 | 3315 | 0.190 |
Why?
|
Thrombosis | 4 | 2009 | 3052 | 0.190 |
Why?
|
Calcium Channel Blockers | 3 | 2017 | 694 | 0.190 |
Why?
|
Software Validation | 1 | 2021 | 59 | 0.190 |
Why?
|
Meningitis, Viral | 1 | 2021 | 50 | 0.190 |
Why?
|
HIV-1 | 2 | 2017 | 6849 | 0.190 |
Why?
|
Renal Insufficiency | 2 | 2021 | 820 | 0.190 |
Why?
|
Nicotine | 2 | 2023 | 677 | 0.180 |
Why?
|
Cross-Sectional Studies | 21 | 2023 | 25942 | 0.180 |
Why?
|
Hyperglycemia | 5 | 2004 | 1380 | 0.180 |
Why?
|
Aortic Valve Insufficiency | 2 | 2016 | 584 | 0.180 |
Why?
|
Healthcare Disparities | 2 | 2014 | 3388 | 0.180 |
Why?
|
Patient Participation | 3 | 2020 | 1439 | 0.180 |
Why?
|
Markov Chains | 4 | 2018 | 968 | 0.180 |
Why?
|
Anticonvulsants | 2 | 2021 | 1879 | 0.180 |
Why?
|
Tobacco Use Cessation | 1 | 2021 | 93 | 0.180 |
Why?
|
Infant, Premature, Diseases | 1 | 2006 | 708 | 0.170 |
Why?
|
Emergency Service, Hospital | 8 | 2019 | 7818 | 0.170 |
Why?
|
Atrial Appendage | 1 | 2024 | 292 | 0.170 |
Why?
|
Recurrence | 9 | 2021 | 8482 | 0.170 |
Why?
|
Sex Factors | 12 | 2018 | 10547 | 0.170 |
Why?
|
Intention to Treat Analysis | 6 | 2021 | 422 | 0.170 |
Why?
|
Nova Scotia | 5 | 2000 | 34 | 0.170 |
Why?
|
Heart Valve Diseases | 2 | 2017 | 1047 | 0.170 |
Why?
|
Neoplasms | 8 | 2024 | 22072 | 0.170 |
Why?
|
Health Resources | 3 | 2024 | 935 | 0.170 |
Why?
|
Sickness Impact Profile | 3 | 2005 | 298 | 0.160 |
Why?
|
Creatine Kinase | 1 | 2021 | 691 | 0.160 |
Why?
|
Patient Transfer | 2 | 2018 | 779 | 0.160 |
Why?
|
Meningitis, Bacterial | 1 | 2021 | 221 | 0.160 |
Why?
|
beta-Alanine | 3 | 2013 | 82 | 0.160 |
Why?
|
Spleen | 1 | 2005 | 2298 | 0.160 |
Why?
|
Biological Transport | 1 | 2023 | 2086 | 0.160 |
Why?
|
Antihypertensive Agents | 3 | 2005 | 2061 | 0.160 |
Why?
|
Continuity of Patient Care | 2 | 2018 | 1066 | 0.160 |
Why?
|
Anti-Bacterial Agents | 9 | 2017 | 7408 | 0.160 |
Why?
|
South Africa | 2 | 2015 | 1821 | 0.160 |
Why?
|
Hospitals, Urban | 1 | 2000 | 499 | 0.150 |
Why?
|
Kidney Failure, Chronic | 2 | 2023 | 2471 | 0.150 |
Why?
|
Mortality | 6 | 2021 | 2916 | 0.150 |
Why?
|
Kaplan-Meier Estimate | 8 | 2018 | 6544 | 0.150 |
Why?
|
Hypoglycemic Agents | 4 | 2006 | 3150 | 0.150 |
Why?
|
Treatment Refusal | 2 | 2003 | 430 | 0.150 |
Why?
|
Analgesics, Non-Narcotic | 2 | 1998 | 370 | 0.150 |
Why?
|
Motivation | 4 | 2015 | 1993 | 0.150 |
Why?
|
Monte Carlo Method | 3 | 2018 | 1257 | 0.150 |
Why?
|
Glucose Intolerance | 3 | 2000 | 580 | 0.150 |
Why?
|
Cost-Benefit Analysis | 10 | 2022 | 5508 | 0.150 |
Why?
|
Basal Metabolism | 1 | 2018 | 161 | 0.150 |
Why?
|
Leiomyoma | 1 | 2022 | 654 | 0.150 |
Why?
|
Heart Failure | 12 | 2022 | 11847 | 0.150 |
Why?
|
Physicians | 4 | 2018 | 4591 | 0.140 |
Why?
|
Electronic Prescribing | 1 | 2018 | 114 | 0.140 |
Why?
|
Encephalitis | 1 | 2021 | 437 | 0.140 |
Why?
|
Patient Acceptance of Health Care | 3 | 2024 | 3164 | 0.140 |
Why?
|
Medicare | 7 | 2024 | 6786 | 0.140 |
Why?
|
Thiazoles | 3 | 2024 | 1511 | 0.140 |
Why?
|
Insurance, Health | 5 | 2017 | 2501 | 0.140 |
Why?
|
Hospitals, General | 3 | 2017 | 795 | 0.140 |
Why?
|
Acetaminophen | 2 | 1998 | 553 | 0.140 |
Why?
|
Speech Recognition Software | 1 | 2017 | 74 | 0.140 |
Why?
|
Secondary Prevention | 4 | 2024 | 1548 | 0.140 |
Why?
|
Liver Cirrhosis | 2 | 2024 | 1931 | 0.140 |
Why?
|
Models, Cardiovascular | 3 | 2018 | 978 | 0.140 |
Why?
|
Sleep Apnea, Obstructive | 2 | 2020 | 1860 | 0.140 |
Why?
|
Automation | 2 | 2020 | 580 | 0.140 |
Why?
|
Disease Management | 3 | 2020 | 2514 | 0.140 |
Why?
|
Tobacco Industry | 1 | 1997 | 135 | 0.140 |
Why?
|
Attitude | 2 | 2023 | 777 | 0.140 |
Why?
|
Algorithms | 8 | 2024 | 13981 | 0.140 |
Why?
|
Adolescent | 41 | 2021 | 87810 | 0.130 |
Why?
|
Intestine, Small | 1 | 2022 | 1207 | 0.130 |
Why?
|
Small-Area Analysis | 2 | 2014 | 55 | 0.130 |
Why?
|
Space Flight | 1 | 2018 | 214 | 0.130 |
Why?
|
Syndrome | 2 | 2019 | 3280 | 0.130 |
Why?
|
Forecasting | 4 | 2013 | 2932 | 0.130 |
Why?
|
Pyridines | 5 | 2024 | 2879 | 0.130 |
Why?
|
Malawi | 1 | 2017 | 301 | 0.130 |
Why?
|
Disease Outbreaks | 2 | 2022 | 1758 | 0.130 |
Why?
|
Diabetes Complications | 2 | 1996 | 1341 | 0.130 |
Why?
|
Aging | 4 | 2013 | 8651 | 0.130 |
Why?
|
Telemetry | 1 | 2017 | 199 | 0.130 |
Why?
|
Organizational Policy | 2 | 2000 | 429 | 0.130 |
Why?
|
Self-Help Groups | 1 | 1997 | 189 | 0.130 |
Why?
|
Comprehensive Health Care | 1 | 1996 | 124 | 0.130 |
Why?
|
Intention | 1 | 2018 | 345 | 0.130 |
Why?
|
Nervous System Diseases | 2 | 2020 | 1647 | 0.130 |
Why?
|
Laminectomy | 1 | 1996 | 224 | 0.130 |
Why?
|
Mitral Valve Insufficiency | 2 | 2016 | 1419 | 0.130 |
Why?
|
Employment | 3 | 2006 | 1112 | 0.120 |
Why?
|
Myocardial Ischemia | 3 | 2022 | 2164 | 0.120 |
Why?
|
Nicotinic Agonists | 1 | 2017 | 265 | 0.120 |
Why?
|
Disease Progression | 6 | 2019 | 13502 | 0.120 |
Why?
|
Hyperinsulinism | 4 | 2000 | 402 | 0.120 |
Why?
|
Peripheral Arterial Disease | 2 | 2019 | 1306 | 0.120 |
Why?
|
Peripheral Nervous System Diseases | 2 | 2019 | 708 | 0.120 |
Why?
|
Off-Label Use | 1 | 2016 | 184 | 0.120 |
Why?
|
Multicenter Studies as Topic | 6 | 2020 | 1722 | 0.120 |
Why?
|
Thrombocytopenia | 1 | 2023 | 1174 | 0.120 |
Why?
|
Health Literacy | 2 | 2017 | 440 | 0.120 |
Why?
|
Dyslipidemias | 1 | 2022 | 895 | 0.120 |
Why?
|
Decision Making | 7 | 2018 | 3925 | 0.120 |
Why?
|
Insulin Resistance | 5 | 2006 | 3959 | 0.120 |
Why?
|
Vaccines | 1 | 2023 | 832 | 0.120 |
Why?
|
Substance-Related Disorders | 4 | 2017 | 4371 | 0.120 |
Why?
|
Cough | 1 | 1998 | 595 | 0.120 |
Why?
|
Heparin, Low-Molecular-Weight | 2 | 2008 | 345 | 0.120 |
Why?
|
Antigens, Tumor-Associated, Carbohydrate | 2 | 1994 | 136 | 0.120 |
Why?
|
Anticholesteremic Agents | 1 | 2001 | 987 | 0.120 |
Why?
|
Drug Resistance, Bacterial | 1 | 2002 | 1055 | 0.120 |
Why?
|
Program Evaluation | 3 | 2009 | 2493 | 0.120 |
Why?
|
Oxygen Inhalation Therapy | 1 | 2017 | 404 | 0.120 |
Why?
|
Adolescent Health Services | 1 | 1996 | 218 | 0.120 |
Why?
|
Family Planning Services | 1 | 1997 | 265 | 0.110 |
Why?
|
Occupational Diseases | 2 | 2000 | 1486 | 0.110 |
Why?
|
Drug Labeling | 1 | 2016 | 251 | 0.110 |
Why?
|
HIV Infections | 3 | 2017 | 17165 | 0.110 |
Why?
|
Maine | 6 | 2006 | 145 | 0.110 |
Why?
|
Benzimidazoles | 3 | 2013 | 858 | 0.110 |
Why?
|
Age Distribution | 5 | 2020 | 2893 | 0.110 |
Why?
|
Cluster Analysis | 2 | 2018 | 2698 | 0.110 |
Why?
|
Hospitals, Municipal | 1 | 1993 | 19 | 0.110 |
Why?
|
Uterine Neoplasms | 1 | 2022 | 1439 | 0.110 |
Why?
|
Monitoring, Physiologic | 5 | 2012 | 1784 | 0.110 |
Why?
|
Therapeutic Human Experimentation | 1 | 1993 | 43 | 0.110 |
Why?
|
Heart Atria | 3 | 2016 | 1346 | 0.110 |
Why?
|
Attitude to Health | 4 | 2017 | 2029 | 0.110 |
Why?
|
Chi-Square Distribution | 8 | 2017 | 3465 | 0.110 |
Why?
|
Mammals | 1 | 2018 | 1131 | 0.110 |
Why?
|
Regression Analysis | 6 | 2016 | 6360 | 0.110 |
Why?
|
Medical Order Entry Systems | 1 | 2018 | 522 | 0.110 |
Why?
|
Embolization, Therapeutic | 1 | 2022 | 1413 | 0.110 |
Why?
|
Diabetic Retinopathy | 5 | 2002 | 1268 | 0.110 |
Why?
|
South America | 1 | 2013 | 181 | 0.110 |
Why?
|
Survival Analysis | 7 | 2014 | 10182 | 0.100 |
Why?
|
Awareness | 1 | 2017 | 646 | 0.100 |
Why?
|
Heart Conduction System | 1 | 2018 | 1015 | 0.100 |
Why?
|
Managed Care Programs | 1 | 1998 | 939 | 0.100 |
Why?
|
Liver | 2 | 2005 | 7509 | 0.100 |
Why?
|
Physicians, Primary Care | 1 | 2019 | 624 | 0.100 |
Why?
|
Cost of Illness | 3 | 2019 | 1940 | 0.100 |
Why?
|
Adrenergic beta-Antagonists | 3 | 2004 | 1259 | 0.100 |
Why?
|
Coronary Artery Disease | 5 | 2019 | 6659 | 0.100 |
Why?
|
Pacemaker, Artificial | 5 | 2012 | 815 | 0.100 |
Why?
|
Immunization | 1 | 1996 | 1227 | 0.100 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2017 | 611 | 0.100 |
Why?
|
Adolescent Behavior | 2 | 1997 | 1175 | 0.100 |
Why?
|
Triglycerides | 5 | 2001 | 2476 | 0.100 |
Why?
|
Appointments and Schedules | 1 | 2016 | 442 | 0.100 |
Why?
|
Photoplethysmography | 2 | 2022 | 60 | 0.100 |
Why?
|
Depression | 4 | 2018 | 8044 | 0.100 |
Why?
|
Prescription Drugs | 1 | 2019 | 630 | 0.100 |
Why?
|
Sex Distribution | 5 | 2015 | 2295 | 0.100 |
Why?
|
Population Surveillance | 2 | 2013 | 2608 | 0.090 |
Why?
|
Vision Screening | 1 | 1992 | 69 | 0.090 |
Why?
|
Creatinine | 5 | 2018 | 1903 | 0.090 |
Why?
|
Ultrasonography | 2 | 2022 | 5961 | 0.090 |
Why?
|
Health Care Surveys | 5 | 2004 | 2435 | 0.090 |
Why?
|
Sinusitis | 3 | 2005 | 990 | 0.090 |
Why?
|
Heparin | 3 | 2020 | 1652 | 0.090 |
Why?
|
Intracranial Thrombosis | 2 | 2009 | 109 | 0.090 |
Why?
|
Maternal Health Services | 1 | 1996 | 455 | 0.090 |
Why?
|
Low Back Pain | 5 | 2005 | 979 | 0.090 |
Why?
|
Hospital Mortality | 4 | 2018 | 5425 | 0.090 |
Why?
|
Arrhythmias, Cardiac | 3 | 2018 | 2255 | 0.090 |
Why?
|
Ischemia | 1 | 2019 | 1893 | 0.090 |
Why?
|
Natriuretic Peptide, Brain | 2 | 2018 | 1717 | 0.090 |
Why?
|
National Heart, Lung, and Blood Institute (U.S.) | 2 | 2023 | 322 | 0.090 |
Why?
|
Acute Disease | 5 | 2016 | 7269 | 0.090 |
Why?
|
Socioeconomic Factors | 9 | 2017 | 7806 | 0.090 |
Why?
|
Atrial Premature Complexes | 1 | 2009 | 17 | 0.090 |
Why?
|
Vulnerable Populations | 1 | 2016 | 696 | 0.090 |
Why?
|
Enzyme Inhibitors | 1 | 2021 | 3726 | 0.090 |
Why?
|
Pneumonia, Pneumococcal | 2 | 2002 | 131 | 0.090 |
Why?
|
Evidence-Based Practice | 1 | 2014 | 496 | 0.090 |
Why?
|
Leg | 2 | 2005 | 1090 | 0.090 |
Why?
|
Communication Barriers | 1 | 2013 | 415 | 0.090 |
Why?
|
Practice Guidelines as Topic | 4 | 2018 | 7475 | 0.080 |
Why?
|
Intubation, Intratracheal | 1 | 2017 | 1328 | 0.080 |
Why?
|
Substance Abuse, Intravenous | 2 | 1993 | 530 | 0.080 |
Why?
|
Linear Models | 4 | 2013 | 5877 | 0.080 |
Why?
|
Vascular Diseases | 1 | 2018 | 1182 | 0.080 |
Why?
|
Antifibrinolytic Agents | 3 | 2014 | 292 | 0.080 |
Why?
|
Parental Consent | 1 | 2009 | 63 | 0.080 |
Why?
|
Health Services Accessibility | 3 | 2018 | 5397 | 0.080 |
Why?
|
Hyperlipidemias | 3 | 2019 | 782 | 0.080 |
Why?
|
Quality of Health Care | 3 | 2019 | 4360 | 0.080 |
Why?
|
Cardiac Surgical Procedures | 3 | 2019 | 3620 | 0.080 |
Why?
|
Accidental Falls | 1 | 2016 | 1056 | 0.080 |
Why?
|
Prenatal Care | 1 | 1996 | 1129 | 0.080 |
Why?
|
Inpatients | 1 | 2000 | 2581 | 0.080 |
Why?
|
Fasting | 5 | 2002 | 1603 | 0.080 |
Why?
|
Infant | 7 | 2023 | 36060 | 0.080 |
Why?
|
Herpes Genitalis | 1 | 2009 | 142 | 0.080 |
Why?
|
Patient-Centered Care | 1 | 2018 | 1416 | 0.080 |
Why?
|
Diet | 2 | 2004 | 8010 | 0.080 |
Why?
|
Ticlopidine | 4 | 2016 | 895 | 0.080 |
Why?
|
Coronary Disease | 7 | 2016 | 5990 | 0.080 |
Why?
|
Seizures | 1 | 2021 | 2917 | 0.080 |
Why?
|
Life Style | 3 | 2023 | 3896 | 0.070 |
Why?
|
Viral Load | 1 | 2017 | 3322 | 0.070 |
Why?
|
Health Status | 7 | 2020 | 4081 | 0.070 |
Why?
|
Glomerular Filtration Rate | 2 | 2021 | 2180 | 0.070 |
Why?
|
Mental Disorders | 2 | 2021 | 6796 | 0.070 |
Why?
|
Anxiety Disorders | 1 | 2018 | 2714 | 0.070 |
Why?
|
Sensitivity and Specificity | 6 | 2023 | 14660 | 0.070 |
Why?
|
Attitude of Health Personnel | 2 | 2004 | 3865 | 0.070 |
Why?
|
Injections, Subcutaneous | 1 | 2008 | 680 | 0.070 |
Why?
|
Qualitative Research | 1 | 2017 | 2963 | 0.070 |
Why?
|
Outpatients | 3 | 2020 | 1607 | 0.070 |
Why?
|
Drug Interactions | 3 | 2021 | 1428 | 0.070 |
Why?
|
Trauma Centers | 2 | 2017 | 933 | 0.070 |
Why?
|
Proteinuria | 1 | 2009 | 594 | 0.070 |
Why?
|
Cocaine | 1 | 1991 | 961 | 0.070 |
Why?
|
Injections, Intravenous | 1 | 2008 | 1385 | 0.060 |
Why?
|
Hypercholesterolemia | 2 | 2003 | 1155 | 0.060 |
Why?
|
Hospitals, University | 2 | 1998 | 568 | 0.060 |
Why?
|
Health Maintenance Organizations | 2 | 2017 | 660 | 0.060 |
Why?
|
Ovarian Neoplasms | 2 | 1994 | 4878 | 0.060 |
Why?
|
Health Services | 1 | 2011 | 753 | 0.060 |
Why?
|
Tachycardia, Ectopic Atrial | 1 | 2006 | 65 | 0.060 |
Why?
|
Splenic Rupture | 1 | 2005 | 26 | 0.060 |
Why?
|
Depressive Disorder | 1 | 2018 | 3726 | 0.060 |
Why?
|
Diabetes Mellitus, Type 1 | 4 | 1996 | 3455 | 0.060 |
Why?
|
Postoperative Complications | 7 | 2020 | 15697 | 0.060 |
Why?
|
Contraception Behavior | 2 | 1998 | 180 | 0.060 |
Why?
|
Recovery of Function | 3 | 2020 | 2985 | 0.060 |
Why?
|
Food Supply | 1 | 2011 | 542 | 0.060 |
Why?
|
Pain | 3 | 2022 | 5066 | 0.060 |
Why?
|
Neonatal Screening | 1 | 2009 | 595 | 0.060 |
Why?
|
Opioid-Related Disorders | 1 | 2019 | 2138 | 0.060 |
Why?
|
ROC Curve | 4 | 2020 | 3568 | 0.060 |
Why?
|
Tomography, X-Ray Computed | 2 | 2005 | 20509 | 0.060 |
Why?
|
Reproducibility of Results | 9 | 2023 | 20080 | 0.060 |
Why?
|
Intensive Care, Neonatal | 1 | 2006 | 197 | 0.060 |
Why?
|
Probability | 3 | 2004 | 2475 | 0.060 |
Why?
|
Hospitals | 3 | 2022 | 3928 | 0.060 |
Why?
|
Malnutrition | 1 | 2011 | 640 | 0.060 |
Why?
|
Needs Assessment | 1 | 2010 | 1139 | 0.060 |
Why?
|
Kyrgyzstan | 1 | 2023 | 3 | 0.060 |
Why?
|
Blood Pressure | 6 | 2018 | 8525 | 0.060 |
Why?
|
Language | 1 | 2013 | 1533 | 0.060 |
Why?
|
Treatment Failure | 2 | 2002 | 2648 | 0.060 |
Why?
|
Patient Selection | 4 | 2017 | 4283 | 0.060 |
Why?
|
Mesentery | 1 | 2004 | 202 | 0.060 |
Why?
|
Health Status Disparities | 1 | 2015 | 1830 | 0.060 |
Why?
|
Tracheostomy | 1 | 2007 | 425 | 0.060 |
Why?
|
National Institutes of Health (U.S.) | 2 | 2009 | 791 | 0.060 |
Why?
|
Analgesics, Opioid | 1 | 2019 | 3763 | 0.050 |
Why?
|
Morbidity | 2 | 2019 | 1765 | 0.050 |
Why?
|
Longitudinal Studies | 5 | 2019 | 14495 | 0.050 |
Why?
|
Telemedicine | 2 | 2021 | 3018 | 0.050 |
Why?
|
Infant, Very Low Birth Weight | 1 | 2006 | 406 | 0.050 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2018 | 3224 | 0.050 |
Why?
|
Infant, Small for Gestational Age | 1 | 2006 | 460 | 0.050 |
Why?
|
Cholesterol, HDL | 3 | 2000 | 1817 | 0.050 |
Why?
|
Anxiety | 1 | 2018 | 4538 | 0.050 |
Why?
|
Lung | 3 | 2018 | 9994 | 0.050 |
Why?
|
Craniocerebral Trauma | 1 | 2007 | 491 | 0.050 |
Why?
|
Hemoglobinometry | 1 | 2002 | 35 | 0.050 |
Why?
|
Prostheses and Implants | 1 | 2009 | 1273 | 0.050 |
Why?
|
Sepsis | 3 | 2013 | 2592 | 0.050 |
Why?
|
Research Support as Topic | 2 | 2009 | 699 | 0.050 |
Why?
|
Statistics as Topic | 4 | 1998 | 2362 | 0.050 |
Why?
|
Fever | 1 | 1990 | 1617 | 0.050 |
Why?
|
Fetal Growth Retardation | 1 | 2006 | 579 | 0.050 |
Why?
|
Deglutition Disorders | 1 | 2007 | 626 | 0.050 |
Why?
|
Vaginal Smears | 1 | 2004 | 495 | 0.050 |
Why?
|
Internationality | 2 | 2018 | 1004 | 0.050 |
Why?
|
Censuses | 1 | 2022 | 201 | 0.050 |
Why?
|
Coronary Care Units | 2 | 1991 | 235 | 0.050 |
Why?
|
Confidence Intervals | 2 | 2004 | 2932 | 0.050 |
Why?
|
Intensive Care Units | 5 | 2002 | 3736 | 0.050 |
Why?
|
Costs and Cost Analysis | 3 | 2006 | 1677 | 0.050 |
Why?
|
Bronchitis, Chronic | 1 | 2002 | 82 | 0.050 |
Why?
|
Neisseria meningitidis | 1 | 2021 | 107 | 0.050 |
Why?
|
Pregnancy | 8 | 2006 | 29749 | 0.050 |
Why?
|
Pneumonia, Bacterial | 2 | 2001 | 319 | 0.050 |
Why?
|
Dengue Virus | 1 | 2003 | 200 | 0.050 |
Why?
|
Hypertrophy, Left Ventricular | 2 | 2018 | 854 | 0.050 |
Why?
|
Enterovirus | 1 | 2021 | 67 | 0.050 |
Why?
|
Molecular Epidemiology | 1 | 2003 | 469 | 0.050 |
Why?
|
Insurance Claim Review | 1 | 2005 | 738 | 0.050 |
Why?
|
Academies and Institutes | 1 | 2023 | 319 | 0.050 |
Why?
|
Patient Education as Topic | 3 | 2017 | 2315 | 0.040 |
Why?
|
Neoplasm Staging | 1 | 2015 | 11152 | 0.040 |
Why?
|
Clinical Trials as Topic | 5 | 2009 | 8056 | 0.040 |
Why?
|
Tennessee | 1 | 2020 | 119 | 0.040 |
Why?
|
Military Personnel | 1 | 2009 | 1244 | 0.040 |
Why?
|
Patient Care Team | 2 | 2018 | 2511 | 0.040 |
Why?
|
Thyroxine | 1 | 2003 | 667 | 0.040 |
Why?
|
Comprehension | 2 | 2017 | 618 | 0.040 |
Why?
|
Clinical Coding | 1 | 2021 | 181 | 0.040 |
Why?
|
Spinal Cord Injuries | 1 | 2007 | 924 | 0.040 |
Why?
|
Family Practice | 2 | 2004 | 510 | 0.040 |
Why?
|
Young Adult | 8 | 2021 | 58741 | 0.040 |
Why?
|
Resuscitation Orders | 1 | 2002 | 270 | 0.040 |
Why?
|
Nausea | 1 | 2022 | 678 | 0.040 |
Why?
|
United States Food and Drug Administration | 2 | 2019 | 1677 | 0.040 |
Why?
|
Dengue | 1 | 2003 | 254 | 0.040 |
Why?
|
Fentanyl | 1 | 2022 | 434 | 0.040 |
Why?
|
Middle East | 1 | 2020 | 230 | 0.040 |
Why?
|
Glycosuria | 3 | 1989 | 44 | 0.040 |
Why?
|
Medical Staff, Hospital | 2 | 2003 | 600 | 0.040 |
Why?
|
Hemostasis | 2 | 2000 | 468 | 0.040 |
Why?
|
Streptococcus pneumoniae | 2 | 2002 | 732 | 0.040 |
Why?
|
Sensation | 1 | 2001 | 331 | 0.040 |
Why?
|
Rectovaginal Fistula | 1 | 1998 | 12 | 0.040 |
Why?
|
Postoperative Period | 2 | 2019 | 1818 | 0.040 |
Why?
|
Internship and Residency | 1 | 2019 | 5870 | 0.040 |
Why?
|
Psychometrics | 2 | 2005 | 3051 | 0.040 |
Why?
|
Anesthesia, Local | 1 | 2001 | 276 | 0.040 |
Why?
|
Physicians, Women | 1 | 2004 | 495 | 0.040 |
Why?
|
Hypothyroidism | 1 | 2003 | 665 | 0.040 |
Why?
|
Heart Valves | 1 | 2000 | 285 | 0.040 |
Why?
|
Cholesterol | 3 | 2003 | 2924 | 0.040 |
Why?
|
Self Care | 2 | 1998 | 793 | 0.040 |
Why?
|
Homocysteine | 1 | 2001 | 640 | 0.040 |
Why?
|
Kidney Diseases | 1 | 2009 | 2093 | 0.040 |
Why?
|
Product Surveillance, Postmarketing | 2 | 2017 | 452 | 0.040 |
Why?
|
Birth Intervals | 1 | 1998 | 51 | 0.040 |
Why?
|
Education | 1 | 2021 | 534 | 0.040 |
Why?
|
Critical Pathways | 1 | 2001 | 475 | 0.040 |
Why?
|
Birth Weight | 1 | 2006 | 2097 | 0.040 |
Why?
|
Specialization | 2 | 2004 | 778 | 0.040 |
Why?
|
Social Support | 2 | 2018 | 2145 | 0.040 |
Why?
|
Magnetic Resonance Imaging | 2 | 2024 | 36290 | 0.040 |
Why?
|
Insulin | 4 | 2001 | 6597 | 0.040 |
Why?
|
Health Services Research | 3 | 2013 | 1810 | 0.040 |
Why?
|
Simplexvirus | 1 | 2021 | 803 | 0.040 |
Why?
|
Combined Modality Therapy | 2 | 2012 | 8552 | 0.040 |
Why?
|
New York | 1 | 2000 | 875 | 0.040 |
Why?
|
Obesity | 5 | 2022 | 12922 | 0.040 |
Why?
|
Blood Transfusion | 2 | 2014 | 1328 | 0.040 |
Why?
|
Risk Adjustment | 1 | 2021 | 601 | 0.040 |
Why?
|
Delivery of Health Care | 3 | 2023 | 5325 | 0.040 |
Why?
|
Brain Concussion | 1 | 1988 | 1394 | 0.040 |
Why?
|
Gestational Age | 1 | 2006 | 3565 | 0.040 |
Why?
|
Immunotherapy | 1 | 2013 | 4642 | 0.040 |
Why?
|
Colorado | 1 | 1997 | 164 | 0.040 |
Why?
|
Brain | 1 | 2024 | 26951 | 0.030 |
Why?
|
Diltiazem | 1 | 2017 | 131 | 0.030 |
Why?
|
Quebec | 1 | 1996 | 142 | 0.030 |
Why?
|
Fertilization | 1 | 1998 | 197 | 0.030 |
Why?
|
Verapamil | 1 | 2017 | 242 | 0.030 |
Why?
|
Prothrombin Time | 2 | 1994 | 116 | 0.030 |
Why?
|
Confidentiality | 1 | 2021 | 609 | 0.030 |
Why?
|
Child | 8 | 2021 | 79806 | 0.030 |
Why?
|
Education, Medical, Graduate | 1 | 2009 | 2363 | 0.030 |
Why?
|
Pulmonary Edema | 3 | 1989 | 409 | 0.030 |
Why?
|
Body Mass Index | 4 | 2017 | 12914 | 0.030 |
Why?
|
Peripheral Vascular Diseases | 1 | 2019 | 515 | 0.030 |
Why?
|
Epidemiologic Factors | 1 | 1996 | 36 | 0.030 |
Why?
|
Blood Coagulation Tests | 1 | 1997 | 270 | 0.030 |
Why?
|
Adverse Drug Reaction Reporting Systems | 1 | 2019 | 488 | 0.030 |
Why?
|
Italy | 1 | 2018 | 841 | 0.030 |
Why?
|
Heart Diseases | 1 | 2009 | 2809 | 0.030 |
Why?
|
Disabled Persons | 2 | 2006 | 1223 | 0.030 |
Why?
|
Models, Statistical | 1 | 2010 | 5075 | 0.030 |
Why?
|
Fecal Incontinence | 1 | 1998 | 241 | 0.030 |
Why?
|
Anal Canal | 1 | 1998 | 372 | 0.030 |
Why?
|
Health Care Costs | 2 | 2023 | 3258 | 0.030 |
Why?
|
Osteoarthritis | 1 | 2003 | 1055 | 0.030 |
Why?
|
Reoperation | 2 | 2005 | 4291 | 0.030 |
Why?
|
Puerperal Disorders | 1 | 1998 | 300 | 0.030 |
Why?
|
Substance Withdrawal Syndrome | 1 | 2000 | 622 | 0.030 |
Why?
|
Physician-Patient Relations | 2 | 2006 | 3242 | 0.030 |
Why?
|
Lumbosacral Region | 1 | 1997 | 291 | 0.030 |
Why?
|
Internet | 2 | 2009 | 3078 | 0.030 |
Why?
|
Quality Indicators, Health Care | 2 | 2017 | 1824 | 0.030 |
Why?
|
Academic Medical Centers | 2 | 2004 | 2754 | 0.030 |
Why?
|
Parents | 1 | 2009 | 3549 | 0.030 |
Why?
|
Statistics, Nonparametric | 2 | 1998 | 2852 | 0.030 |
Why?
|
Australia | 1 | 2019 | 1289 | 0.030 |
Why?
|
Intestines | 1 | 2004 | 1907 | 0.030 |
Why?
|
New York City | 1 | 2017 | 724 | 0.030 |
Why?
|
Nutrition Surveys | 1 | 2022 | 1725 | 0.030 |
Why?
|
Emergency Medicine | 1 | 2004 | 1196 | 0.030 |
Why?
|
Myocardial Revascularization | 1 | 2019 | 841 | 0.030 |
Why?
|
Consumer Health Information | 1 | 2017 | 209 | 0.030 |
Why?
|
Quality Control | 1 | 2017 | 828 | 0.030 |
Why?
|
Nephrology | 1 | 2018 | 263 | 0.030 |
Why?
|
Factor Analysis, Statistical | 1 | 1997 | 998 | 0.030 |
Why?
|
Cardiomyopathy, Dilated | 1 | 2020 | 819 | 0.030 |
Why?
|
Atrial Function, Left | 1 | 2016 | 186 | 0.030 |
Why?
|
Streptococcal Infections | 2 | 1998 | 617 | 0.030 |
Why?
|
Parity | 1 | 1998 | 925 | 0.030 |
Why?
|
Apolipoproteins E | 1 | 2000 | 1436 | 0.030 |
Why?
|
Hospital Costs | 1 | 2000 | 976 | 0.030 |
Why?
|
User-Computer Interface | 1 | 2021 | 1403 | 0.030 |
Why?
|
Medical Records | 1 | 2000 | 1407 | 0.030 |
Why?
|
District of Columbia | 1 | 2014 | 160 | 0.030 |
Why?
|
Medicine | 2 | 2004 | 943 | 0.030 |
Why?
|
Heart | 2 | 2023 | 4393 | 0.030 |
Why?
|
Anesthetics, Local | 1 | 2001 | 1001 | 0.030 |
Why?
|
Geography | 1 | 2016 | 661 | 0.030 |
Why?
|
Hospital Bed Capacity, 300 to 499 | 1 | 1993 | 57 | 0.030 |
Why?
|
Intracranial Embolism and Thrombosis | 1 | 1993 | 144 | 0.030 |
Why?
|
Thrombophilia | 1 | 2016 | 306 | 0.030 |
Why?
|
Diastole | 1 | 2016 | 788 | 0.030 |
Why?
|
Mammography | 1 | 2004 | 2427 | 0.030 |
Why?
|
Area Under Curve | 1 | 2017 | 1636 | 0.030 |
Why?
|
Hematoma, Subdural | 1 | 1994 | 126 | 0.030 |
Why?
|
Anthropometry | 1 | 1998 | 1348 | 0.030 |
Why?
|
Child, Preschool | 3 | 2021 | 42063 | 0.030 |
Why?
|
Cornea | 1 | 2001 | 1326 | 0.030 |
Why?
|
Phenotype | 3 | 2020 | 16546 | 0.030 |
Why?
|
Quality Assurance, Health Care | 2 | 2001 | 2176 | 0.030 |
Why?
|
Coronary Thrombosis | 1 | 2016 | 486 | 0.030 |
Why?
|
Death, Sudden | 1 | 2015 | 302 | 0.030 |
Why?
|
Evaluation Studies as Topic | 2 | 1993 | 1628 | 0.030 |
Why?
|
Triage | 2 | 1990 | 987 | 0.030 |
Why?
|
Light Coagulation | 1 | 1992 | 71 | 0.030 |
Why?
|
Alcohol-Related Disorders | 1 | 2014 | 235 | 0.030 |
Why?
|
Pandemics | 2 | 2023 | 8624 | 0.030 |
Why?
|
Cost Savings | 2 | 2012 | 920 | 0.030 |
Why?
|
Commerce | 1 | 1997 | 605 | 0.030 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2004 | 2003 | 0.020 |
Why?
|
Peer Group | 1 | 1997 | 674 | 0.020 |
Why?
|
Perception | 1 | 2018 | 1195 | 0.020 |
Why?
|
Angina Pectoris | 2 | 1989 | 969 | 0.020 |
Why?
|
Carotid Artery Diseases | 1 | 2018 | 883 | 0.020 |
Why?
|
Arginine | 1 | 2015 | 934 | 0.020 |
Why?
|
China | 1 | 2017 | 2339 | 0.020 |
Why?
|
Health Surveys | 2 | 2017 | 4063 | 0.020 |
Why?
|
Infant, Newborn | 4 | 2009 | 26181 | 0.020 |
Why?
|
Diabetic Foot | 1 | 1994 | 381 | 0.020 |
Why?
|
Activities of Daily Living | 1 | 2000 | 2417 | 0.020 |
Why?
|
Analgesics | 1 | 2017 | 1065 | 0.020 |
Why?
|
Anti-Infective Agents | 1 | 1998 | 981 | 0.020 |
Why?
|
Radioimmunoassay | 1 | 1991 | 866 | 0.020 |
Why?
|
Oxygen | 2 | 2017 | 4193 | 0.020 |
Why?
|
Hemoglobins | 1 | 2016 | 1521 | 0.020 |
Why?
|
Palliative Care | 1 | 2005 | 3607 | 0.020 |
Why?
|
Data Interpretation, Statistical | 1 | 1999 | 2696 | 0.020 |
Why?
|
Health Care Rationing | 1 | 1993 | 435 | 0.020 |
Why?
|
International Cooperation | 1 | 2016 | 1433 | 0.020 |
Why?
|
Polymorphism, Genetic | 1 | 2000 | 4291 | 0.020 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2004 | 3334 | 0.020 |
Why?
|
Analysis of Variance | 3 | 2009 | 6238 | 0.020 |
Why?
|
Drug Synergism | 1 | 2013 | 1754 | 0.020 |
Why?
|
Staphylococcal Infections | 1 | 1998 | 1407 | 0.020 |
Why?
|
Myocardium | 2 | 1993 | 4700 | 0.020 |
Why?
|
Human Experimentation | 1 | 2009 | 123 | 0.020 |
Why?
|
Stroke Volume | 2 | 2016 | 5523 | 0.020 |
Why?
|
Lymphatic Diseases | 1 | 1990 | 319 | 0.020 |
Why?
|
Delayed Diagnosis | 1 | 2012 | 464 | 0.020 |
Why?
|
Early Diagnosis | 1 | 2013 | 1180 | 0.020 |
Why?
|
Thallium | 1 | 1987 | 100 | 0.020 |
Why?
|
Diabetic Nephropathies | 1 | 1994 | 988 | 0.020 |
Why?
|
Uremia | 1 | 1988 | 201 | 0.020 |
Why?
|
Clinical Protocols | 1 | 2013 | 1440 | 0.020 |
Why?
|
Chronic Disease | 3 | 2009 | 9287 | 0.020 |
Why?
|
Wounds and Injuries | 1 | 2020 | 2477 | 0.020 |
Why?
|
Dipyridamole | 1 | 1987 | 143 | 0.020 |
Why?
|
Cardiac Output | 1 | 1969 | 838 | 0.020 |
Why?
|
Pregnancy in Diabetics | 1 | 1988 | 194 | 0.020 |
Why?
|
Physicians, Family | 1 | 2009 | 349 | 0.020 |
Why?
|
Epidemiology | 1 | 2009 | 278 | 0.020 |
Why?
|
Self Report | 1 | 2018 | 3711 | 0.020 |
Why?
|
Shock, Septic | 1 | 2013 | 761 | 0.020 |
Why?
|
Cardiac Resynchronization Therapy | 1 | 2012 | 553 | 0.020 |
Why?
|
Endocarditis, Bacterial | 1 | 1990 | 445 | 0.020 |
Why?
|
Epidemiologic Methods | 1 | 1991 | 1343 | 0.020 |
Why?
|
Hemangiosarcoma | 1 | 1988 | 216 | 0.020 |
Why?
|
Trauma Severity Indices | 1 | 2007 | 478 | 0.020 |
Why?
|
Radioisotopes | 1 | 1987 | 495 | 0.020 |
Why?
|
Blood Glucose Self-Monitoring | 1 | 1989 | 457 | 0.020 |
Why?
|
Calcium Channels | 1 | 1989 | 619 | 0.020 |
Why?
|
Lisinopril | 1 | 2005 | 55 | 0.020 |
Why?
|
Financing, Government | 1 | 2009 | 472 | 0.020 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 1994 | 2197 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 2015 | 6538 | 0.020 |
Why?
|
Hydrochlorothiazide | 1 | 2005 | 94 | 0.020 |
Why?
|
Atenolol | 1 | 2005 | 99 | 0.020 |
Why?
|
Alcohol Drinking | 1 | 1998 | 4013 | 0.020 |
Why?
|
Urine | 1 | 1986 | 363 | 0.020 |
Why?
|
Heart Neoplasms | 1 | 1988 | 360 | 0.010 |
Why?
|
Kenya | 1 | 2007 | 749 | 0.010 |
Why?
|
Nursing Assessment | 1 | 2004 | 106 | 0.010 |
Why?
|
Heart Valve Prosthesis Implantation | 1 | 2015 | 1582 | 0.010 |
Why?
|
Piperazines | 1 | 2015 | 2525 | 0.010 |
Why?
|
Hospital Bed Capacity, 500 and over | 1 | 1983 | 114 | 0.010 |
Why?
|
Carotid Arteries | 1 | 1988 | 951 | 0.010 |
Why?
|
Eating | 1 | 2011 | 1539 | 0.010 |
Why?
|
Immunologic Factors | 1 | 2013 | 1588 | 0.010 |
Why?
|
Mentors | 1 | 2009 | 661 | 0.010 |
Why?
|
Fluoroscopy | 1 | 2007 | 948 | 0.010 |
Why?
|
Echocardiography | 1 | 2016 | 4981 | 0.010 |
Why?
|
Antidepressive Agents, Tricyclic | 1 | 1985 | 432 | 0.010 |
Why?
|
Aortic Valve Stenosis | 1 | 2016 | 2065 | 0.010 |
Why?
|
Radiography | 3 | 2001 | 6965 | 0.010 |
Why?
|
Air Conditioning | 1 | 2003 | 54 | 0.010 |
Why?
|
Insurance, Pharmaceutical Services | 1 | 2005 | 345 | 0.010 |
Why?
|
Insurance Coverage | 1 | 2014 | 1939 | 0.010 |
Why?
|
Poverty | 1 | 2014 | 2695 | 0.010 |
Why?
|
Nutritional Status | 1 | 2011 | 1607 | 0.010 |
Why?
|
Patient Readmission | 3 | 1998 | 3323 | 0.010 |
Why?
|
Suicide, Attempted | 1 | 1991 | 1378 | 0.010 |
Why?
|
Partial Thromboplastin Time | 1 | 2003 | 205 | 0.010 |
Why?
|
Aedes | 1 | 2003 | 97 | 0.010 |
Why?
|
Diagnosis-Related Groups | 1 | 1983 | 450 | 0.010 |
Why?
|
Otorhinolaryngologic Surgical Procedures | 1 | 2005 | 323 | 0.010 |
Why?
|
Cardiac Pacing, Artificial | 1 | 2006 | 866 | 0.010 |
Why?
|
Texas | 1 | 2003 | 401 | 0.010 |
Why?
|
Publishing | 1 | 2009 | 836 | 0.010 |
Why?
|
Vitamin K 1 | 1 | 2001 | 47 | 0.010 |
Why?
|
Tetracaine | 1 | 2001 | 34 | 0.010 |
Why?
|
Educational Status | 2 | 1999 | 2515 | 0.010 |
Why?
|
RNA, Messenger | 2 | 1993 | 12766 | 0.010 |
Why?
|
Clinical Medicine | 1 | 2002 | 145 | 0.010 |
Why?
|
Radiography, Abdominal | 1 | 2004 | 532 | 0.010 |
Why?
|
Utilization Review | 1 | 2002 | 383 | 0.010 |
Why?
|
Pharmacists | 1 | 2003 | 259 | 0.010 |
Why?
|
Nerve Tissue Proteins | 1 | 1993 | 4407 | 0.010 |
Why?
|
Research | 1 | 2009 | 1974 | 0.010 |
Why?
|
Isoelectric Focusing | 1 | 2000 | 160 | 0.010 |
Why?
|
Half-Life | 1 | 2001 | 652 | 0.010 |
Why?
|
Mexico | 1 | 2003 | 760 | 0.010 |
Why?
|
Blood Gas Analysis | 1 | 2001 | 379 | 0.010 |
Why?
|
Efficiency | 1 | 1983 | 477 | 0.010 |
Why?
|
Bacteriological Techniques | 1 | 2001 | 279 | 0.010 |
Why?
|
Blotting, Northern | 2 | 1993 | 1543 | 0.010 |
Why?
|
Heart Transplantation | 1 | 1993 | 3224 | 0.010 |
Why?
|
Pelvis | 1 | 2004 | 743 | 0.010 |
Why?
|
Lung Diseases | 1 | 1990 | 1915 | 0.010 |
Why?
|
Blood Viscosity | 1 | 2000 | 124 | 0.010 |
Why?
|
Focus Groups | 1 | 2005 | 1378 | 0.010 |
Why?
|
Leadership | 1 | 2009 | 1371 | 0.010 |
Why?
|
Community Health Centers | 1 | 2003 | 453 | 0.010 |
Why?
|
Syncope | 1 | 1982 | 428 | 0.010 |
Why?
|
Complement C1 | 1 | 1979 | 32 | 0.010 |
Why?
|
Lipoproteins, VLDL | 1 | 2000 | 201 | 0.010 |
Why?
|
Coronary Artery Bypass | 1 | 1988 | 2272 | 0.010 |
Why?
|
Immune Complex Diseases | 1 | 1979 | 52 | 0.010 |
Why?
|
Blood | 1 | 2001 | 586 | 0.010 |
Why?
|
Infant, Premature | 1 | 1988 | 2092 | 0.010 |
Why?
|
Emergencies | 1 | 1985 | 1211 | 0.010 |
Why?
|
Meta-Analysis as Topic | 1 | 2003 | 1376 | 0.010 |
Why?
|
Fibrinolysis | 1 | 2000 | 332 | 0.010 |
Why?
|
Vitamin B 12 | 1 | 2001 | 522 | 0.010 |
Why?
|
Oximetry | 1 | 2001 | 461 | 0.010 |
Why?
|
Vascular Surgical Procedures | 1 | 1987 | 1475 | 0.010 |
Why?
|
Infusions, Intravenous | 1 | 2003 | 2234 | 0.010 |
Why?
|
Quality Improvement | 1 | 2013 | 3836 | 0.010 |
Why?
|
Otolaryngology | 1 | 2005 | 685 | 0.010 |
Why?
|
Immunoglobulin M | 1 | 2003 | 1529 | 0.010 |
Why?
|
Lidocaine | 1 | 2001 | 538 | 0.010 |
Why?
|
Bupivacaine | 1 | 2001 | 413 | 0.010 |
Why?
|
Animals | 4 | 2018 | 167963 | 0.010 |
Why?
|
Albuminuria | 1 | 2001 | 659 | 0.010 |
Why?
|
Erythromycin | 1 | 1997 | 117 | 0.010 |
Why?
|
Immunocompetence | 1 | 1997 | 138 | 0.010 |
Why?
|
Antigen-Antibody Complex | 1 | 1979 | 513 | 0.010 |
Why?
|
Emergency Medical Services | 1 | 1988 | 1925 | 0.010 |
Why?
|
Travel | 1 | 2003 | 785 | 0.010 |
Why?
|
Documentation | 1 | 2003 | 893 | 0.010 |
Why?
|
Glomerulonephritis | 1 | 1979 | 337 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 2004 | 21025 | 0.010 |
Why?
|
Rural Population | 1 | 2007 | 2268 | 0.010 |
Why?
|
Contraceptive Agents, Female | 1 | 1998 | 118 | 0.010 |
Why?
|
Environment | 1 | 2003 | 1118 | 0.010 |
Why?
|
Health Education | 1 | 2003 | 1049 | 0.010 |
Why?
|
Risk Reduction Behavior | 1 | 2003 | 1109 | 0.010 |
Why?
|
Canada | 1 | 2002 | 2128 | 0.010 |
Why?
|
Manometry | 1 | 1998 | 453 | 0.010 |
Why?
|
Endoscopy | 1 | 2005 | 1838 | 0.010 |
Why?
|
Sex Characteristics | 1 | 2005 | 2629 | 0.010 |
Why?
|
Lipoproteins | 1 | 2000 | 882 | 0.010 |
Why?
|
Maternal Age | 1 | 1998 | 807 | 0.010 |
Why?
|
Women's Health | 1 | 2004 | 2056 | 0.010 |
Why?
|
Folic Acid | 1 | 2001 | 1309 | 0.010 |
Why?
|
Endosonography | 1 | 1998 | 607 | 0.010 |
Why?
|
Pregnancy Complications | 1 | 1988 | 2942 | 0.010 |
Why?
|
Models, Biological | 1 | 1991 | 9467 | 0.010 |
Why?
|
Blood Transfusion, Autologous | 1 | 1994 | 132 | 0.010 |
Why?
|
Nurses | 1 | 2003 | 2467 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2013 | 18137 | 0.010 |
Why?
|
Diagnosis, Differential | 2 | 2000 | 12965 | 0.010 |
Why?
|
Radionuclide Imaging | 2 | 1988 | 1975 | 0.010 |
Why?
|
Bacteremia | 1 | 2000 | 980 | 0.010 |
Why?
|
Pleural Effusion | 1 | 1996 | 342 | 0.010 |
Why?
|
Prothrombin | 1 | 1993 | 191 | 0.010 |
Why?
|
Pleurisy | 1 | 1993 | 54 | 0.010 |
Why?
|
Pulse | 1 | 1993 | 218 | 0.010 |
Why?
|
Atrial Natriuretic Factor | 1 | 1993 | 350 | 0.010 |
Why?
|
Family Characteristics | 1 | 1998 | 1001 | 0.010 |
Why?
|
Hematocrit | 1 | 1994 | 629 | 0.010 |
Why?
|
Diabetic Neuropathies | 2 | 1986 | 406 | 0.010 |
Why?
|
Hospitals, Veterans | 1 | 1993 | 398 | 0.010 |
Why?
|
Cholesterol, LDL | 1 | 2000 | 2420 | 0.010 |
Why?
|
Fluorocarbon Polymers | 1 | 1969 | 14 | 0.010 |
Why?
|
Cardiac Complexes, Premature | 1 | 1969 | 63 | 0.010 |
Why?
|
Coccidioidomycosis | 1 | 1990 | 37 | 0.010 |
Why?
|
Health Status Indicators | 1 | 1995 | 968 | 0.010 |
Why?
|
Stainless Steel | 1 | 1969 | 79 | 0.010 |
Why?
|
Pulmonary Veins | 1 | 1975 | 745 | 0.010 |
Why?
|
Histoplasmosis | 1 | 1990 | 63 | 0.010 |
Why?
|
In Situ Hybridization | 1 | 1993 | 1900 | 0.010 |
Why?
|
Neurologic Examination | 1 | 1993 | 916 | 0.010 |
Why?
|
Pain Measurement | 1 | 1999 | 3528 | 0.010 |
Why?
|
Lung Diseases, Fungal | 1 | 1990 | 126 | 0.010 |
Why?
|
Tuberculin Test | 1 | 1990 | 206 | 0.010 |
Why?
|
Gallium Radioisotopes | 1 | 1990 | 195 | 0.010 |
Why?
|
Extracorporeal Circulation | 1 | 1969 | 182 | 0.010 |
Why?
|
Homeostasis | 1 | 2000 | 3306 | 0.010 |
Why?
|
Communication | 1 | 2003 | 3849 | 0.010 |
Why?
|
Auscultation | 1 | 1988 | 38 | 0.010 |
Why?
|
Alleles | 1 | 2000 | 6898 | 0.000 |
Why?
|
Restriction Mapping | 1 | 1989 | 852 | 0.000 |
Why?
|
Reimbursement Mechanisms | 1 | 1994 | 664 | 0.000 |
Why?
|
Behavior | 1 | 1991 | 540 | 0.000 |
Why?
|
Heart Ventricles | 2 | 1993 | 3811 | 0.000 |
Why?
|
Peptidyl-Dipeptidase A | 1 | 1990 | 361 | 0.000 |
Why?
|
Heart Block | 1 | 1969 | 392 | 0.000 |
Why?
|
Hip Prosthesis | 1 | 1994 | 920 | 0.000 |
Why?
|
Bradycardia | 1 | 1969 | 299 | 0.000 |
Why?
|
Cardiac Volume | 1 | 1988 | 199 | 0.000 |
Why?
|
Xenopus | 1 | 1989 | 717 | 0.000 |
Why?
|
Electrodes | 1 | 1969 | 614 | 0.000 |
Why?
|
Cognition | 1 | 1984 | 6957 | 0.000 |
Why?
|
Decision Trees | 1 | 1988 | 506 | 0.000 |
Why?
|
Respiration | 1 | 1993 | 1654 | 0.000 |
Why?
|
Chest Pain | 1 | 1993 | 1106 | 0.000 |
Why?
|
Hemodynamics | 1 | 1975 | 4174 | 0.000 |
Why?
|
Oocytes | 1 | 1989 | 1165 | 0.000 |
Why?
|
Sarcoidosis | 1 | 1990 | 520 | 0.000 |
Why?
|
Bronchoscopy | 1 | 1990 | 911 | 0.000 |
Why?
|
Equipment Failure | 1 | 1986 | 577 | 0.000 |
Why?
|
Cloning, Molecular | 1 | 1989 | 4169 | 0.000 |
Why?
|
Intelligence Tests | 1 | 1984 | 500 | 0.000 |
Why?
|
Tuberculosis, Pulmonary | 1 | 1990 | 831 | 0.000 |
Why?
|
Erectile Dysfunction | 1 | 1986 | 452 | 0.000 |
Why?
|
Rabbits | 1 | 1989 | 4773 | 0.000 |
Why?
|
Bayes Theorem | 1 | 1990 | 2326 | 0.000 |
Why?
|
Gene Expression | 1 | 1993 | 7588 | 0.000 |
Why?
|
Peptide Fragments | 1 | 1993 | 5125 | 0.000 |
Why?
|
Lymphoma | 1 | 1990 | 1898 | 0.000 |
Why?
|
Aorta | 1 | 1987 | 2039 | 0.000 |
Why?
|
Pneumonia, Viral | 1 | 1996 | 3205 | 0.000 |
Why?
|
Preoperative Care | 1 | 1987 | 2256 | 0.000 |
Why?
|
Pregnancy Outcome | 1 | 1988 | 2907 | 0.000 |
Why?
|
Amino Acid Sequence | 1 | 1989 | 13451 | 0.000 |
Why?
|
Molecular Sequence Data | 1 | 1989 | 17624 | 0.000 |
Why?
|
Kidney Glomerulus | 1 | 1979 | 568 | 0.000 |
Why?
|
Complement System Proteins | 1 | 1979 | 782 | 0.000 |
Why?
|
Immunoglobulins | 1 | 1979 | 859 | 0.000 |
Why?
|
Learning | 1 | 1984 | 1739 | 0.000 |
Why?
|
Pulmonary Atelectasis | 1 | 1975 | 143 | 0.000 |
Why?
|
Respiration, Artificial | 1 | 1985 | 2622 | 0.000 |
Why?
|
Pulmonary Fibrosis | 1 | 1975 | 506 | 0.000 |
Why?
|
Congenital Abnormalities | 1 | 1975 | 704 | 0.000 |
Why?
|
Cognition Disorders | 1 | 1984 | 3976 | 0.000 |
Why?
|
Pneumonectomy | 1 | 1975 | 1111 | 0.000 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 1979 | 2159 | 0.000 |
Why?
|